News

Maximizing Total Returns: The Key to Sustainable Income

Maximizing Total Returns: The Key to Sustainable Income

Understanding Total Returns in Investing

In the world of investing, especially for income-focused investors, the ultimate goal is achieving a balance between a reliable income and an appealing growth potential. This combination is often referred to as total return. It encompasses both the dividends received and the growth in the stock's price, creating a holistic approach to portfolio building.

When examining dividend yields, many investors are attracted to high payouts without fully considering the underlying performance of the stock. A striking case in point is Prospect Capital Corporation (NASDAQ: PSEC), which boasts an eye-catching 21.1% yield. However, this allure often masks an essential truth: the sustainability and growth potential of such high yields can be questionable.

For instance, an investment of $100,000 in PSEC may tempt many with the promise of $1,758 in monthly dividends. But is this really in the best interests of a long-term investor?

The Reality Check: Total Returns Necessitate Consideration

Upon examining PSEC’s historical performance, one finds that it produced an 85% total return over an extended period of 21 years. This figure includes dividends, translating to an annualized return of approximately 3%. Such performance, when compared against the more stable U.S. government bonds, raises concerns about the risks associated with chasing high yields.

This situation highlights a critical lesson—focusing solely on high dividends can lead to significant disappointment. Conversely, adopting a conservative strategy with lower yields isn’t always the solution either. A more balanced perspective is needed.

Strategic Yield Selection: The Middle Road

An excellent illustration of this balanced approach can be found in the State Street SPDR S&P Dividend ETF (NYSE: SDY). Although it offers a relatively modest yield of 2.6%, it has consistently outperformed PSEC in total return over the past decade. This underscores the importance of considering not only the yield, but also the potential for capital appreciation and overall return stability.

Strategy plays a vital role here: targeting yields in the 8% to 10% range tends to strike a better balance between income generation and sustainability. While this might seem ambitious, history suggests that a fund invested in strong, blue-chip stocks can comfortably deliver this performance.

Positioning for Success with Liberty All-Star Equity Fund

A fine example of this strategy is found in the Liberty All-Star Equity Fund (NYSE: USA). This closed-end fund aims for a yield slightly exceeding 10%, while historically providing the necessary returns to support that payout. The USA fund has outshined SDY due to its effective management strategy and consistent growth in dividends.

Furthermore, USA is committed to distributing 10% of its net asset value to shareholders annually, indicating a reliable income stream. This dynamic not only enhances investor confidence but positions the fund for consistent performance amidst market fluctuations.

Leveraging Discounts for Higher Gains

Additionally, it’s essential to consider market conditions and the trading dynamics of closed-end funds like USA. These funds often trade at discounts to their net asset value, allowing savvy investors to purchase shares at lower prices. This provides a unique opportunity to capture both dividend income and potential price appreciation when the premium returns.

For instance, someone who acquired shares of USA at a steep discount in the past decade, only to sell during peak market conditions, would have not only earned substantial dividends but also realized impressive capital gains.

The strategy of rotating investments among well-priced, high-yield opportunities helps create a more resilient and diversified portfolio. This tactic doesn’t just capture dividend income; it opens doors for additional growth potential—essentially creating a dual pathway to financial success.

Conclusion: Beyond the Yield

Ultimately, while high dividend yields may seem enticing, it’s crucial for investors to look beyond immediate returns and consider a broader strategy that encompasses total returns. By focusing on well-performing funds like USA and maintaining a disciplined investment approach, you can safeguard your portfolio against volatility while positioning yourself for a secure financial future.

Frequently Asked Questions

What is total return in investing?

Total return refers to the overall gain or loss made on an investment, including both dividend payments and capital appreciation.

Why should I consider both dividends and price growth?

Opting for a holistic approach helps balance income with growth potential, which is vital for long-term financial security.

How can high dividend yields be risky?

High yields can often lead to capital losses if the underlying stock performance declines significantly, resulting in subpar returns.

What’s the ideal yield range for a balanced portfolio?

Aiming for yields between 8% to 10% is often seen as a sweet spot that provides a sustainable income without excessive risk.

How do discounts affect closed-end funds?

Buying a closed-end fund at a discount allows investors to achieve higher yields based on market pricing, increasing the overall return potential.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Chemours Faces Class Action Over Fraud Allegations

Updated Category News Views 206

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 112

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 63

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Lunit, Summit Tackle Tumor Analysis with AI Platform

Updated Category News Views 212

Amid whispers of AI revolutionizing every industry, let's zero in on its latest pit stop—oncology R&D. Lunit, shaking hands with Summit Therapeutics, plans to bring artificial intelligence into the tumor microenvironment analysis game, thanks to the Lunit SCOPE IO platform. This isn't just another lab experiment; it's a step towards redefining how we understand cancer's...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 66

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 35

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 46

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 27

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 89

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading

Top 5 Most Recently Viewed Articles

Fresh Del Monte's Sustainability Report Shows Significant Progress

Updated Category News Views 200

Fresh Del Monte's 2023 Sustainability Goals Fresh Del Monte Produce Inc. (NYSE: FDP), a prominent player in the global fruit and vegetable market, has released its sustainability report for the year, highlighting a remarkable journey toward environmental stewardship. This report showcases the substantial progress Fresh Del Monte has made in its sustainability initiatives,...

Continue Reading
MEXC Enhances User Security with New Compliance Measures

Updated Category News Views 118

MEXC Enhances User Security with New Compliance Measures MEXC, a prominent cryptocurrency exchange renowned for its global reach, has taken significant steps to enhance risk control and compliance protocols aimed at safeguarding users and ensuring the market's integrity. The organization remains committed to eradicating fraudulent behaviors and enhancing compliance...

Continue Reading
Market Insights: Asian Shares and Economic Influences

Updated Category News Views 154

Mixed Outcomes in Asian Markets Asian shares displayed a blend of positive and negative trends as markets reacted to the recent surge in U.S. stocks, which reached new peaks to end a successful trading week. U.S. futures reflected this mixed sentiment, while oil prices experienced an upward trend. Performance of Key Indices In Hong Kong, the Hang Seng index dropped 1.5%...

Continue Reading
Understanding Recent CPSC Recalls and Safety Measures

Updated Category News Views 280

Understanding Recent CPSC Recalls and Safety Measures The Consumer Product Safety Commission (CPSC) plays a crucial role in safeguarding the public from hazards associated with consumer products. Recently, several recalls have been announced to protect consumers from potential risks. These recalls, conducted in cooperation with various firms, aim to address safety...

Continue Reading
Significant Advancements in Lymphedema Treatment Using Flexitouch® Plus

Updated Category News Views 213

Groundbreaking Results from Flexitouch® Plus Study In an exciting development for medical technology, Tactile Systems Technology, Inc. (Nasdaq: TCMD) has presented remarkable findings from a recent late-breaking poster session at a prominent rehabilitation medicine conference. The data highlights the sustained clinical benefits of Flexitouch® Plus as a primary therapy...

Continue Reading